Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial.
Sign Up to like & getrecommendations! Published in 2020 at "European journal of cancer"
DOI: 10.1016/j.ejca.2020.02.008
Abstract: AIM To evaluate treatment-related toxicity, treatment compliance, surgical complications and event-free survival (EFS) in older (≥70 years) versus younger ( read more here.
Keywords: younger adults; perioperative treatment; versus younger; cancer ... See more keywords
Preliminary efficacy and safety of perioperative treatment of camrelizumab combined with apatinib in resectable hepatocellular carcinoma (HCC): A prospective phase II study.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.4082
Abstract: 4082 Background: Although there is no standard perioperative treatment for resectable HCC characterized with high recurrence rate, the strategy of immunotherapy combined with targeted agents is promising in neoadjuvant/adjuvant therapy in various tumors. Methods: In… read more here.
Keywords: hcc; treatment; treatment camrelizumab; perioperative treatment ... See more keywords
Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15030566
Abstract: Simple Summary The risk of recurrence of patients with localized muscle-invasive bladder carcinoma (MIBC) is still high. The outcomes of surgery and perioperative therapy are limited, and several patients are not candidates for neoadjuvant chemotherapy… read more here.
Keywords: perioperative treatment; treatment; invasive bladder; muscle invasive ... See more keywords